Sponsors

Enalees opens German subsidiary

Veterinary diagnostics firm Enalees has announced the opening of a new subsidiary in Germany and the appointment of Philip Hausen as general manager for the Germany-Austria-Switzerland (DACH) region.

As the second opening of a European subsidiary, following the UK in November 2022, this strengthens the company’s mission to structure a European group dedicated to supporting veterinary professionals with rapid animal diagnostics.

Enalees is prioritising the introduction on the German market of its equine Epona range of products. Over the last 12 months, the number of equine clinics in Germany using its innovative solution has tripled. Their loyalty is demonstrated by a sharp increase of 73% in purchases (2021-2022). The company then plans to introduce the Astéria range for cats and dogs to the German market, before expanding its sales pipeline into Austria and Switzerland.

The German veterinary healthcare market is expected to see growth of 4.5% by 2027, which makes it an ideal location for Enalees’ second European subsidiary. Part of the global equine veterinary therapeutics market, the equine diagnosis segment held a dominant market share in 2021. This is estimated to be the fastest-growing segment, with a compound annual growth rate of 6.8% over the forecast period 2022-2032.

The creation of the German subsidiary is aimed at supporting existing and new German customers on a daily basis, with a dedicated team offering tailored molecular diagnostics solutions to meet customers’ specific needs.

With over 30 years of experience in human and animal health and a proven track record of successfully launching and developing brands in competitive markets, Philip Hausen (pictured above) is perfectly suited to lead Enalees’ German subsidiary. His professional experience includes working with companies such as Bayer, Elanco and VetPlus.

“I am excited to join Enalees as general manager for the DACH region in this once-in-a-lifetime opportunity to build up a German subsidiary and to launch Enalees’ technology into this market. I am impressed by the expert products and convinced they will play a pivotal role in the daily routine of veterinary practices in the future,” said Philip Hausen.

Enalees plans to strengthen its commercial team throughout 2023, by hiring more territory and office managers to structure and boost commercial activity to gain new market shares. The company’s new German offices are located in Monheim am Rhein, a business-friendly city located between Cologne and Düsseldorf. Enalees will continue to build financial momentum to fulfil its goals of hiring new talent, furthering staff training and supporting the launch of new products.

 

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025